Tactile Systems Technology, Inc.
TCMDHealthcareNASDAQMedical Devices
Headquartered within the healthcare sector, Tactile Systems Technology, Inc. focuses on Medical Devices services and products. Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. At a $648.3M market cap, Tactile Systems Technology, Inc. ranks as a small-cap company within healthcare. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds.
Market Cap
$648.3M
Beta
0.79
P/E (TTM)
33.81
P/E (Fwd)
19.10
EPS (TTM)
$0.85
EPS (Fwd)
$1.50
ROE
9.6%
ROA
7.3%
Cash
$75.0M
Total Debt
$15.2M
Free CF
$33.5M
52W Change
201.9%
Annual Financials
Cash vs Debt
Tactile Systems Technology, Inc. holds $75.0M in cash against $15.2M in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. Free cash flow comes in at $33.5M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of 9.6% points to decent capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 7.3% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $246.8M (2022) to $329.5M (2025), reflecting a 34% increase over the period.
The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Tactile Systems Technology, Inc. and its sector.